Isopropyl Alcohol

Isopropyl Alcohol

SCHEMBL5771119

CC(C)O.O=CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114646693-A Method for detecting polysorbate80 content in biological preparation 沈阳三生制药有限责任公司 2022-06-21 CN claimed
EP-2885295-A1 SOLID FORMS OF AN ANTIVIRAL COMPOUND Gilead Sciences, Inc. (US) 2015-06-24 EP claimed
WO-2014028343-A1 SOLID FORMS OF AN ANTIVIRAL COMPOUND GILEAD SCIENCES, INC. (US) 2014-02-20 WO claimed
CN-115993422-A Determination of polysorbates 上海复宏汉霖生物技术股份有限公司 2023-04-21 CN disclosed
CN-110785420-B Oxazepin derivatives as inhibitors of PI 3-kinase activity 葛兰素史克知识产权开发有限公司 2022-04-26 CN disclosed
US-11254651-B2 Histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2022-02-22 US disclosed
CN-112691082-A Solid preparation containing telmisartan in compound form and preparation method thereof 海南涛生医药科技研究院有限公司 2021-04-23 CN disclosed
EP-3149486-A1 METHOD FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT Biocross, S.L. (ES) 2017-04-05 EP disclosed
CN-103492377-B As the triazolopyridine compounds of PIM kinase inhibitor ARRAY BIOPHARMA INC. (US) 2016-04-20 CN disclosed
WO-2015181391-A1 METHOD FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT BIOCROSS, S.L. (ES) 2015-12-03 WO disclosed
CN-103118767-B Separation method DUPONT NUTRITION BIOSCI APS 2015-05-20 CN disclosed
EP-1301516-B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK AS (DK) 2006-03-22 EP disclosed
US-6613903-B2 Such as 7-(benzoylamino-methyl)-2-(oxalyl-amino)-4,5,6,7-tetrahydro-thieno(2,3 -c)pyridine-3-carboxylic acid for treatment of diabetes, insulin resistance, and obesity NOVO NORDISK A/S (DK) 2003-09-02 US disclosed
EP-1301516-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2003-04-16 EP disclosed
US-20030027354-A1 Device for the analysis of chemical or biochemical specimens, comparative analysis, and associated analysis process GELI FRANCOIS (FR) 2003-02-06 US disclosed
US-20020151561-A1 Modulators of Protein Tyrosine Phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-10-17 US disclosed
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US disclosed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO disclosed
US-4900850-A Recovery of purified ditertiary butyl peroxide TEXACO INC. (US) 1990-02-13 US disclosed
US-4810809-A MULTISTAGE DISTILLATION SOLVENT EXTRACTION OF AZEOTROPE TEXACO INC. (US) 1989-03-07 US disclosed